Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist

Stephan Seitz; Florian Hohla; Andrew V Schally; Angelika Moder; Joerg B Engel; Felicitas Horn; Josef Varga; Marta Zarandi; Olaf Ortmann; Frank Köster; Stefan Buchholz

doi:10.3892/or_00000143

Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist

Stephan Seitz
, Florian Hohla (Co-author)
, Andrew V Schally
, Angelika Moder
, Joerg B Engel
, Felicitas Horn
, Josef Varga
, Marta Zarandi
, Olaf Ortmann
, Frank Köster
, Stefan Buchholz

Institute of Physiology and Pathophysiology Salzburg

Research output: Contribution to journal › Original Article › peer-review

11 Citations (Web of Science)

Original language	English
Pages (from-to)	1289-1294
Journal	ONCOLOGY REPORTS
Volume	20
Issue number	5
DOIs	https://doi.org/10.3892/or_00000143
Publication status	Published - 2008

Keywords

ACTIVATED PROTEIN-KINASE
SPLICE VARIANTS
MESSENGER-RNA
IN-VITRO
PANCREATIC-CANCER
GHRH RECEPTORS
IGF-I
EXPRESSION
PROLIFERATION
MECHANISMS

Access to Document

10.3892/or_00000143

Cite this

Seitz, S., Hohla, F., Schally, A. V., Moder, A., Engel, J. B., Horn, F., Varga, J., Zarandi, M., Ortmann, O., Köster, F., & Buchholz, S. (2008). Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist. ONCOLOGY REPORTS , 20(5), 1289-1294. https://doi.org/10.3892/or_00000143

Seitz, Stephan ; Hohla, Florian ; Schally, Andrew V et al. / Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist. In: ONCOLOGY REPORTS 2008 ; Vol. 20, No. 5. pp. 1289-1294.

@article{838bbd65885d4249bd292a68d3ead789,

title = "Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist",

keywords = "ACTIVATED PROTEIN-KINASE, SPLICE VARIANTS, MESSENGER-RNA, IN-VITRO, PANCREATIC-CANCER, GHRH RECEPTORS, IGF-I, EXPRESSION, PROLIFERATION, MECHANISMS",

author = "Stephan Seitz and Florian Hohla and Schally, \{Andrew V\} and Angelika Moder and Engel, \{Joerg B\} and Felicitas Horn and Josef Varga and Marta Zarandi and Olaf Ortmann and Frank K{\"o}ster and Stefan Buchholz",

year = "2008",

doi = "10.3892/or\_00000143",

language = "English",

volume = "20",

pages = "1289--1294",

journal = "ONCOLOGY REPORTS ",

issn = "1021-335X",

number = "5",

}

Seitz, S, Hohla, F, Schally, AV, Moder, A, Engel, JB, Horn, F, Varga, J, Zarandi, M, Ortmann, O, Köster, F & Buchholz, S 2008, 'Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist', ONCOLOGY REPORTS , vol. 20, no. 5, pp. 1289-1294. https://doi.org/10.3892/or_00000143

Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist. / Seitz, Stephan; Hohla, Florian (Co-author); Schally, Andrew V et al.
In: ONCOLOGY REPORTS , Vol. 20, No. 5, 2008, p. 1289-1294.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist

AU - Seitz, Stephan

AU - Hohla, Florian

AU - Schally, Andrew V

AU - Moder, Angelika

AU - Engel, Joerg B

AU - Horn, Felicitas

AU - Varga, Josef

AU - Zarandi, Marta

AU - Ortmann, Olaf

AU - Köster, Frank

AU - Buchholz, Stefan

PY - 2008

Y1 - 2008

KW - ACTIVATED PROTEIN-KINASE

KW - SPLICE VARIANTS

KW - MESSENGER-RNA

KW - IN-VITRO

KW - PANCREATIC-CANCER

KW - GHRH RECEPTORS

KW - IGF-I

KW - EXPRESSION

KW - PROLIFERATION

KW - MECHANISMS

U2 - 10.3892/or_00000143

DO - 10.3892/or_00000143

M3 - Original Article

C2 - 18949435

SN - 1021-335X

VL - 20

SP - 1289

EP - 1294

JO - ONCOLOGY REPORTS

JF - ONCOLOGY REPORTS

IS - 5

ER -

Seitz S, Hohla F, Schally AV, Moder A, Engel JB, Horn F et al. Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist. ONCOLOGY REPORTS . 2008;20(5):1289-1294. doi: 10.3892/or_00000143